Stemgent is a brand of REPROCELL, a leading supplier of cellular reprogramming products and services and tissue-based research, Under the Stemgent brand, REPROCELL provides a comprehensive portfolio of tools for cell research, and is recognized as expert in stem cell reprogramming, provide mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services. ReproCELL Incorporated ReproCELL was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business, succeeding in the commercialization of the world's first human iPS cell products in 2009 and with the world's most advanced research and technology. In addition, through the recent acquisitions of Reinnervate (UK), BioServe (US), and Stemgent (US), ReproCELL is proceeding towards the establishment of a global distribution network, and technology synergy and new product introductions.